Article thumbnail

Computational Detection and Functional Analysis of Human Tissue-Specific A-to-I RNA Editing

By Tao He, Qiong Wang, Guihai Feng, Yaou Hu, Li Wang and Yumin Wang

Abstract

A-to-I RNA editing is a widespread post-transcriptional modification event in vertebrates. It could increase transcriptome and proteome diversity through recoding the genomic information and cross-linking other regulatory events, such as those mediated by alternative splicing, RNAi and microRNA (miRNA). Previous studies indicated that RNA editing can occur in a tissue-specific manner in response to the requirements of the local environment. We set out to systematically detect tissue-specific A-to-I RNA editing sites in 43 human tissues using bioinformatics approaches based on the Fisher's exact test and the Benjamini & Hochberg false discovery rate (FDR) multiple testing correction. Twenty-three sites in total were identified to be tissue-specific. One of them resulted in an altered amino acid residue which may prevent the phosphorylation of PARP-10 and affect its activity. Eight and two tissue-specific A-to-I RNA editing sites were predicted to destroy putative exonic splicing enhancers (ESEs) and exonic splicing silencers (ESSs), respectively. Brain-specific and ovary-specific A-to-I RNA editing sites were further verified by comparing the cDNA sequences with their corresponding genomic templates in multiple cell lines from brain, colon, breast, bone marrow, lymph, liver, ovary and kidney tissue. Our findings help to elucidate the role of A-to-I RNA editing in the regulation of tissue-specific development and function, and the approach utilized here can be broadened to study other types of tissue-specific substitution editing

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3063316
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1987). A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine.
  2. (2008). A-to-I RNA editing and cancer: from pathology to basic science.
  3. (2006). A-to-I RNA editing and human disease.
  4. (2009). ADAR1 and ADAR2 expression and editing activity during forebrain development.
  5. (2007). Altered adenosine-to-inosine RNA editing in human cancer.
  6. (2010). Alternative splicing and extensive RNA editing of human TPH2 transcripts.
  7. (2010). Alu sequences in undifferentiated human embryonic stem cells display high levels of A-to-I RNA editing.
  8. (2006). An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers.
  9. (2005). Biased alternative polyadenylation in human tissues.
  10. (2003). C-to-U RNA editing: mechanisms leading to genetic diversity.
  11. (1997). Cell type-specific loss of atp6 RNA editing in cytoplasmic male sterile Sorghum bicolor.
  12. (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing.
  13. (2004). CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion.
  14. (2003). Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences.
  15. (2003). ESEfinder: A web resource to identify exonic splicing enhancers.
  16. (1999). Exhaustive mining of EST libraries for genes differentially expressed in normal and tumour tissues.
  17. (2003). Expanding genome capacity via RNA editing. C R Biol 326: 901–908. Tissue-Specific A-to-I
  18. (2008). Frequency and fate of microRNA editing in human brain.
  19. (2010). Functions and regulation of RNA editing by ADAR deaminases.
  20. (2006). General and specific functions of exonic splicing silencers in splicing control.
  21. (2006). Genetic variation in the zebrafish.
  22. (2002). Genome-wide detection of tissue-specific alternative splicing in the human transcriptome.
  23. (2009). Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing.
  24. (2004). Improved prediction of signal peptides:
  25. (2005). Is there any sense in antisense editing?
  26. (2010). Large-scale detection and analysis of RNA editing in grape mtDNA by RNA deepsequencing.
  27. (2009). Large-scale mRNA sequencing determines global regulation of RNA editing during brain development.
  28. (2006). miRBase: microRNA sequences, targets and gene nomenclature.
  29. (2008). miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes.
  30. (2006). Modulation of microRNA processing and expression through RNA editing by ADAR deaminases.
  31. (2007). NetCGlyc 1.0: prediction of mammalian C-mannosylation sites. Glycobiology 17: 868–876. Tissue-Specific A-to-I
  32. (2008). NONCODE v2.0: decoding the non-coding.
  33. (2005). PARP10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation.
  34. (1992). Prediction of gene structure.
  35. (2004). Prediction of proprotein convertase cleavage sites.
  36. (2005). Prediction, conservation analysis, and structural characterization of mammalian mucin-type Oglycosylation sites.
  37. (2007). Redirection of silencing targets by adenosine-to-inosine editing of miRNAs.
  38. (1999). Regulation of alternative splicing by RNA editing.
  39. (2007). RNA editing and alternative splicing of the insect nAChR subunit alpha6 transcript: evolutionary conservation, divergence and regulation.
  40. (2006). RNA editing and alternative splicing: the importance of co-transcriptional coordination.
  41. (2002). RNA editing by adenosine deaminases generates RNA and protein diversity.
  42. (2002). RNA editing by adenosine deaminases that act on RNA.
  43. (2004). RNA editing generates tissuespecific sodium channels with distinct gating properties.
  44. (2007). RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex.
  45. (2007). Seemingly neutral polymorphic variants may confer immunity to splicinginactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer.
  46. (1999). Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.
  47. (2004). Systematic identification and analysis of exonic splicing silencers.
  48. (2008). The UCSC Genome Browser Database:
  49. (2008). TiGER: a database for tissuespecific gene expression and regulation.
  50. (2004). Widespread A-to-I RNA editing of Alucontaining mRNAs in the human transcriptome.
  51. (2004). Widespread RNA editing of embedded alu elements in the human transcriptome.